Usefulness of [99mTc]MIBI and [18F]fluorodeoxyglucose for imaging recurrent medullary thyroid cancer and hyperparathyroidism in MEN 2a syndrome

被引:5
作者
Roelants, V [1 ]
Michel, L [1 ]
Lonneux, M [1 ]
Lacrosse, M [1 ]
Delgrange, E [1 ]
Donckier, JE [1 ]
机构
[1] Univ Hosp Mont Godinne, Dept Internal Med & Endocrinol, B-5530 Yvoir, Belgium
来源
ACTA CLINICA BELGICA | 2001年 / 56卷 / 06期
关键词
medullary thyroid cancer; Tc-99m]MIBI; FDG-PET;
D O I
10.1179/acb.2001.057
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report the case of a MEN 2a patient with a history of medullary thyroid cancer (MTC) treated by total thyroidectomy, who presented an increasing calcitonin level, suggesting tumor recurrence. Conventional radiographic and radionuclide imaging failed to localize the responsible lesions. A planar and tomographic (SPECT) [Tc-99m]MIBI scan, performed in order to investigate a recent hyperparathyroidism localized a parathyroid adenoma and revealed an abnormal uptake in the left lateral neck region, corresponding to apparently banal lymph nodes on MRI. This abnormal uptake was also observed on a [F-18]fluorodeoxyglucose positron emission tomography (FDG-PET) study and was proven to be an uptake in MTC lymph nodes metastases as confirmed by histopathologic analysis. We conclude that, using an adequate acquisition protocol (i.e. SPECT), [Tc-99m]MIBI scan is potentially able to localize both parathyroid adenoma and recurrent MTC at one and the same time, particularly in case of non-diagnostic conventional imaging techniques. In this setting, the potential usefulness of FDG-PET is also discussed.
引用
收藏
页码:373 / 377
页数:5
相关论文
共 19 条
[1]   Determination of medullary thyroid carcinoma metastases by 201Tl, 99Tcm(V)DMSA, 99Tcm-MIBI and 99Tcm-tetrofosmin [J].
Adalet, I ;
Koçak, M ;
Oguz, H ;
Alagöl, F ;
Cantez, S .
NUCLEAR MEDICINE COMMUNICATIONS, 1999, 20 (04) :353-359
[2]  
Adams S, 1998, EUR J NUCL MED, V25, P79
[3]   Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings [J].
Adams, S ;
Baum, RP ;
Hertel, A ;
Schumm-Draeger, PM ;
Usadel, KH ;
Hör, G .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (09) :1277-1283
[4]   The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer [J].
Brandt-Mainz, K ;
Müller, SP ;
Görges, R ;
Saller, B ;
Bockisch, A .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (05) :490-496
[5]   Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography [J].
Conti, PS ;
Durski, JM ;
Bacqai, F ;
Grafton, ST ;
Singer, PA .
THYROID, 1999, 9 (08) :797-804
[6]  
Delbeke D, 1999, J NUCL MED, V40, P591
[7]  
DORR U, 1993, HORM METAB RES, V27, P48
[8]   Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma [J].
Gasparoni, P ;
Rubello, D ;
Ferlin, G .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1997, 20 (09) :527-530
[9]   Advances and controversies in the diagnosis and management of medullary thyroid carcinoma [J].
Heshmati, HM ;
Gharib, H ;
vanHeerden, JA ;
Sizemore, GW .
AMERICAN JOURNAL OF MEDICINE, 1997, 103 (01) :60-69
[10]  
HOWE JR, 1993, SURGERY, V114, P1070